Related Experiment Video
Updated: Apr 3, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
[Interaction between miR-21 and DNA methylation in different breast cancer cells]
Objective:
To determine the interaction between miR-21 and DNA methylation in different breast cancer cells.
Methods:
Fluorescence tagged miR-21 inhibitor and its negative control (NC) were transient transfected into MCF-7 and MDA-MB-231 cell, the transfection efficiency was observed using fluorescence microscopy, and the miR-21 expression level and genome DNA methylation status before and after transfection were assessed by real-time PCR and bisulfite-qMSP respectively. To investigate the regulation effect of DNA methylation on miR-21, cells were treated with 5-AZA (2.5 µmol/L) for 72 h, with dimethyl sulfoxide (DMSO) treatment as its negative control (NC), and the expression level of phosphatase and tensin homolog deleted on chromosome ten (PTEN) and AKT(also known as Protein Kinase B), two downstream genes of miR-21 were detected by Western blot.
Results:
The expression of miR-21 in MCF-7 cell was significantly knocked down (P < 0.01) by miR-21 inhibitor, with the genome DNA methylation level (P < 0.05) and all the three Dnmts: Dnmt1, Dnmt3a, and Dnmt3b unregulated. In contrast, the miR-21 expression in MDA-MB-231 cell was elevated ( P < 0.01) by miR-21 inhibitor, meanwhile, down- regulated of genome DNA methylation (P < 0.05) and Dnmt3b expression, upregulation of Dnmt3a were also observed. In addition, treated with 5-AZA resulted in significant increases of miR-21 expression in both MCF-7 and MDA-MB-231 cells (P < 0.01), with the protein level of PTEN increased in MCF-7 cell, which was further involved in the downregulation of AKT.
Conclusion:
The regulation effects of DNA methylation by transient transfection of miR-21 in MCF-7 and MDA-MB-231 cells are almost opposite, whilst the expression of miR-21 in two cell lines were all upregulated by decreased DNA methylation level and our results may provide some experimental evidences for the future development of rational therapy for different breast cancer.
Insights
MicroRNA-21 (miR-21) interacts with DNA methylation differently in breast cancer cells. Decreased DNA methylation upregulates miR-21, impacting cancer therapy development.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- MicroRNA-21 (miR-21) is implicated in various cancers, including breast cancer.
- DNA methylation is a key epigenetic mechanism regulating gene expression.
- The interplay between miR-21 and DNA methylation in breast cancer subtypes remains incompletely understood.
Purpose of the Study:
- To elucidate the interaction between miR-21 and DNA methylation in distinct breast cancer cell lines (MCF-7 and MDA-MB-231).
- To investigate the regulatory effects of DNA methylation on miR-21 expression and its downstream targets.
Main Methods:
- Transfection of miR-21 inhibitors and negative controls into MCF-7 and MDA-MB-231 cells.
- Assessment of miR-21 expression via real-time PCR.
- Evaluation of genome-wide DNA methylation status using bisulfite-qMSP.
- Treatment with 5-aza-2'-deoxycytidine (5-AZA) to modulate DNA methylation.
- Western blot analysis to detect protein levels of PTEN and AKT.
Main Results:
- In MCF-7 cells, miR-21 inhibition led to decreased miR-21 expression and unregulated DNA methylation and DNMTs.
- In MDA-MB-231 cells, miR-21 inhibition paradoxically increased miR-21 expression, alongside decreased genome-wide DNA methylation and altered DNMT expression (Dnmt3b downregulated, Dnmt3a upregulated).
- 5-AZA treatment significantly increased miR-21 expression in both cell lines, elevated PTEN protein levels in MCF-7 cells, and influenced AKT signaling.
Conclusions:
- DNA methylation exhibits opposing regulatory effects on miR-21 in MCF-7 and MDA-MB-231 cells.
- Decreased DNA methylation consistently upregulates miR-21 expression across both tested breast cancer cell lines.
- Findings provide experimental evidence supporting the development of targeted therapies for diverse breast cancer subtypes based on miR-21 and DNA methylation interactions.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
MicroRNAs
MicroRNAs
Abnormal Proliferation

